EP1663231A4 - ORRACONAZOLE ORAL COMPOSITION NOT AFFECTED BY INGREDIENT FOOD AND PROCESS FOR PREPARING THE SAME - Google Patents

ORRACONAZOLE ORAL COMPOSITION NOT AFFECTED BY INGREDIENT FOOD AND PROCESS FOR PREPARING THE SAME

Info

Publication number
EP1663231A4
EP1663231A4 EP04774524A EP04774524A EP1663231A4 EP 1663231 A4 EP1663231 A4 EP 1663231A4 EP 04774524 A EP04774524 A EP 04774524A EP 04774524 A EP04774524 A EP 04774524A EP 1663231 A4 EP1663231 A4 EP 1663231A4
Authority
EP
European Patent Office
Prior art keywords
orraconazole
affected
preparing
same
oral composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04774524A
Other languages
German (de)
French (fr)
Other versions
EP1663231A1 (en
Inventor
Jong Soo Woo
Hong Gi Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Original Assignee
Hanmi Pharmaceutical Co Ltd
Hanmi Pharmaceutical Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharmaceutical Co Ltd, Hanmi Pharmaceutical Industries Co Ltd filed Critical Hanmi Pharmaceutical Co Ltd
Priority claimed from PCT/KR2004/002264 external-priority patent/WO2005023262A1/en
Publication of EP1663231A1 publication Critical patent/EP1663231A1/en
Publication of EP1663231A4 publication Critical patent/EP1663231A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP04774524A 2003-09-09 2004-09-07 ORRACONAZOLE ORAL COMPOSITION NOT AFFECTED BY INGREDIENT FOOD AND PROCESS FOR PREPARING THE SAME Withdrawn EP1663231A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2003-0063147A KR100529766B1 (en) 2003-09-09 2003-09-09 Oral itraconazole composition which is not affected by ingested food and preparation thereof
PCT/KR2004/002264 WO2005023262A1 (en) 2003-09-09 2004-09-07 Oral itraconazole composition which is not affected by ingested food and process for preparing same

Publications (2)

Publication Number Publication Date
EP1663231A1 EP1663231A1 (en) 2006-06-07
EP1663231A4 true EP1663231A4 (en) 2009-04-29

Family

ID=36096818

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04774524A Withdrawn EP1663231A4 (en) 2003-09-09 2004-09-07 ORRACONAZOLE ORAL COMPOSITION NOT AFFECTED BY INGREDIENT FOOD AND PROCESS FOR PREPARING THE SAME

Country Status (10)

Country Link
EP (1) EP1663231A4 (en)
JP (1) JP2007505103A (en)
KR (1) KR100529766B1 (en)
CN (1) CN100475211C (en)
AU (1) AU2004270069B2 (en)
BR (1) BRPI0414192A (en)
CA (1) CA2538019C (en)
IL (1) IL173743A (en)
MX (1) MXPA06002239A (en)
RU (1) RU2006111477A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200065093A (en) 2012-06-21 2020-06-08 메인 파마 인터내셔널 프로프라이어터리 리미티드 Itraconazole compositions and dosage forms, and methods of using the same
CN104688536B (en) * 2015-02-03 2016-06-08 常州制药厂有限公司 A kind of preparation method of itraconazole preparation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000179A1 (en) * 1998-06-27 2000-01-06 Won Jin Biopharma Co., Ltd. Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof
WO2000059475A1 (en) * 1999-04-06 2000-10-12 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR20020054573A (en) * 2000-12-28 2002-07-08 민경윤 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof
KR20030000799A (en) * 2001-06-27 2003-01-06 한미약품공업 주식회사 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000000179A1 (en) * 1998-06-27 2000-01-06 Won Jin Biopharma Co., Ltd. Solid dispersed preparation of poorly water-soluble drug containing oil, fatty acid or mixtures thereof
WO2000059475A1 (en) * 1999-04-06 2000-10-12 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR20020054573A (en) * 2000-12-28 2002-07-08 민경윤 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof
KR20030000799A (en) * 2001-06-27 2003-01-06 한미약품공업 주식회사 Composition for oral administration of poorly soluble antifungal agent and process for the preparation thereof

Also Published As

Publication number Publication date
KR20050026169A (en) 2005-03-15
AU2004270069A1 (en) 2005-03-17
IL173743A0 (en) 2006-07-05
AU2004270069B2 (en) 2008-03-13
JP2007505103A (en) 2007-03-08
BRPI0414192A (en) 2006-10-31
MXPA06002239A (en) 2006-06-20
EP1663231A1 (en) 2006-06-07
CN1849123A (en) 2006-10-18
CA2538019C (en) 2009-09-01
CN100475211C (en) 2009-04-08
RU2006111477A (en) 2006-08-27
KR100529766B1 (en) 2005-11-17
CA2538019A1 (en) 2005-03-17
IL173743A (en) 2012-08-30

Similar Documents

Publication Publication Date Title
FR2836915B1 (en) AMINOINDAZOLE DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
IL165977A (en) Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same
HUP0400989A3 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them
EE04464B1 (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
FR2882554B1 (en) IVABRADINE HYDROCHLORIDE BETA D-CRYSTALLINE FORM, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2862647B1 (en) PYRAZOLYL DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
IL162765A (en) Diazabicycle derivatives, processes for their preparation, pharmaceutical compositions comprising them and their medical use
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
FR2840302B1 (en) ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
EP1515966A4 (en) HYDROXY PYRANONE DERIVATIVE AND PROCESS FOR PREPARING THE SAME
FR2833259B1 (en) PROCESS FOR THE PREPARATION OF 2-ARYLBENZOFURANES, INTERMEDIATE COMPOUNDS, 2-ARYLBENZOFURANES AND COMPOSITIONS COMPRISING THE SAME
FR2833596B1 (en) PROCESS FOR THE PREPARATION OF ECHINOCANDIN DERIVATIVES
FR2842525B1 (en) 3-GUANIDINOCARBONYL-1-HETEROARYL-INDOLE DERIVATIVES, PROCESS FOR THE PREPARATION AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
FR2883876B1 (en) INDANYL-PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP1587792A4 (en) STABLE, AMORPHOUS AMLODIPINE CAMSYLATE, METHOD FOR PREPARING THE SAME AND COMPOSITION FOR ORAL ADMINISTRATION
EP1740531A4 (en) INDENE DERIVATIVES AND PROCESS FOR PREPARING THE SAME
EP1663231A4 (en) ORRACONAZOLE ORAL COMPOSITION NOT AFFECTED BY INGREDIENT FOOD AND PROCESS FOR PREPARING THE SAME
DE60200023D1 (en) Isoindoloindolone derivatives, process for their preparation and the pharmaceutical compositions containing them
EP1565448A4 (en) PROCESS FOR THE PREPARATION OF 10H-DIBENZO B, F 1,4 THIAZEPIN-11-ONE
EP1551831A4 (en) PROCESS FOR PREPARING THE RISPERIDONE
DE60200041D1 (en) Indenoindolone derivatives, process for their preparation and the pharmaceutical compositions containing them
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
HUP0303455A3 (en) Imidazolidine derivatives, their preparation and pharmaceutical compositions containing them
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTALENES

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090331

17Q First examination report despatched

Effective date: 20090715

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101026